ProPhase Labs, Inc. (NASDAQ: PRPH) - concise operating & income-statement snapshot
Quick take:
- Company pivoting from diagnostics/manufacturing to genomics, consumer products and diagnostics IP (BE‑Smart™, Equivir, Linebacker).
- Major corporate moves in H1 2025: sale of Pharmaloz/PMI (closed Ja...